Literature DB >> 33535186

A novel risk model to predict first-ever ischemic stroke in heart failure with reduced ejection fraction.

Xiaodong Zhou1, Lingfang Yu2, Weizhen Hu1, Ruiyu Shi1, Yinan Ji1, Changzuan Zhou1, Chenglong Xue3, Guojia Yu3, Weijian Huang1, Peiren Shan1,3.   

Abstract

Patients with heart failure are at increased risk for ischemic stroke. We aim to develop a more accurate stroke risk prediction tools identify high-risk patients with heart failure with reduced ejection fraction (HFrEF). Patient data were extracted retrospectively from the electronic medical database between January 2009 and February 2019. Univariate and multivariate Cox regression analysis were performed to identify independent predictors, which were utilized to construct a nomogram for predicting ischemic stroke. AUROC analysis was used to compare the prognostic value between the new risk score and CHADS2/CHA2DS2-VASc scores. In 6087 patients with HFrEF, the risk of first-ever ischemic stroke was 5.8% events/pts-years (n=468) during 8007.2 person-years follow-up. A nomogram constructed by integrating 6 variables, including age, atrial fibrillation (AF), deep vein thrombosis (DVT), d-dimer, anticoagulant use and spontaneous echocardiographic contrast (SEC)/left ventricular thrombus (LVT), exhibited a greater area under the curve of 0.727, 0.728 and 0.714 than that by CHADS2 score (0.515, 0.522 and 0.540), and by CHA2DS2-VASc score (0.547, 0.553 and 0.562) for predicting first-ever ischemic stroke at hospitalization, 30-day and 6-month follow-up (all p<0.001). This novel stroke risk score performed better than existing CHADS2/ CHA2DS2-VASc scores and showed improvement in predicting first-ever ischemic stroke in HFrEF patients.

Entities:  

Keywords:  heart failure with reduced ejection fraction; ischemic stroke; predictors; score model

Year:  2021        PMID: 33535186      PMCID: PMC7950228          DOI: 10.18632/aging.202458

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  33 in total

1.  Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.

Authors:  Line Melgaard; Anders Gorst-Rasmussen; Deidre A Lane; Lars Hvilsted Rasmussen; Torben Bjerregaard Larsen; Gregory Y H Lip
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

Review 2.  The incidence of ischemic stroke in chronic heart failure: a meta-analysis.

Authors:  Brandi J Witt; Apoor S Gami; Karla V Ballman; Robert D Brown; Ryan A Meverden; Stephen J Jacobsen; Véronique L Roger
Journal:  J Card Fail       Date:  2007-08       Impact factor: 5.712

3.  Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study.

Authors:  Dennis V Cokkinos; George C Haralabopoulos; John B Kostis; Pavlos K Toutouzas
Journal:  Eur J Heart Fail       Date:  2006-06-05       Impact factor: 15.534

4.  Ischemic stroke after heart failure: a community-based study.

Authors:  Brandi J Witt; Robert D Brown; Steven J Jacobsen; Susan A Weston; Karla V Ballman; Ryan A Meverden; Véronique L Roger
Journal:  Am Heart J       Date:  2006-07       Impact factor: 4.749

Review 5.  Biomarkers in atrial fibrillation: a clinical review.

Authors:  Ziad Hijazi; Jonas Oldgren; Agneta Siegbahn; Christopher B Granger; Lars Wallentin
Journal:  Eur Heart J       Date:  2013-02-05       Impact factor: 29.983

6.  Blood pressure and stroke in heart failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Patrick M Pullicino; Leslie A McClure; Virginia G Wadley; Ali Ahmed; Virginia J Howard; George Howard; Monika M Safford
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

7.  Heart failure and the risk of stroke: the Rotterdam Study.

Authors:  V P Alberts; M J Bos; P J Koudstaal; A Hofman; J C M Witteman; B H C Stricker; M M B Breteler
Journal:  Eur J Epidemiol       Date:  2010-11       Impact factor: 8.082

8.  The predictive role of CHA2DS2-VASc score between venous thromboembolism and ischemic stroke: a large-scale cohort study.

Authors:  Wei-Syun Hu; Cheng-Li Lin
Journal:  J Hypertens       Date:  2018-03       Impact factor: 4.844

9.  The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure.

Authors:  J G F Cleland; I Findlay; S Jafri; G Sutton; R Falk; C Bulpitt; C Prentice; I Ford; Adele Trainer; P A Poole-Wilson
Journal:  Am Heart J       Date:  2004-07       Impact factor: 4.749

10.  Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.

Authors:  Ludvig B Rinde; Birgit Småbrekke; Ellisiv B Mathiesen; Maja-Lisa Løchen; Inger Njølstad; Erin M Hald; Tom Wilsgaard; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  J Am Heart Assoc       Date:  2016-11-07       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.